Asthma Clinical Trials in Oklahoma City, Oklahoma

8 studies are recruiting for asthma in Oklahoma City, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

   To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.

   Stage

   Phase 3

   Ages

   5 to 11

   Site

   Research Site, Oklahoma City, Oklahoma

   Locations

   147 in total

   Run by

   AstraZeneca

   See if you can join NCT06023589 on ClinicalTrials.gov

2. A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

   The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   GSK Investigational Site, Oklahoma City, Oklahoma

   Locations

   67 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT05757102 on ClinicalTrials.gov

3. A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

   The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety …

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Teva Investigational Site 12178, Oklahoma City, Oklahoma

   Locations

   189 in total

   Run by

   Teva Branded Pharmaceutical Products R&D LLC

   See if you can join NCT06664619 on ClinicalTrials.gov

4. A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

   The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

   Stage

   Phase 2

   Ages

   4 to 11

   Site

   Research Site, Oklahoma City, Oklahoma

   Locations

   43 in total

   Run by

   AstraZeneca

   See if you can join NCT07525375 on ClinicalTrials.gov

5. A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

   The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).

   Stage

   Phase 3

   Ages

   12 and older

   Site

   GSK Investigational Site, Oklahoma City, Oklahoma

   Locations

   17 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT07456033 on ClinicalTrials.gov

6. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

   The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   Research Site, Oklahoma City, Oklahoma

   Locations

   150 in total

   Run by

   AstraZeneca

   See if you can join NCT06307665 on ClinicalTrials.gov

7. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

   The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning o…

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   Allergy, Asthma and Clinical Research, Oklahoma City, Oklahoma

   Locations

   132 in total

   Run by

   Pfizer

   See if you can join NCT06977581 on ClinicalTrials.gov

8. Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma

   The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.

   Stage

   Not phased

   Ages

   18 to 99

   Site

   OUHSC, Oklahoma City, Oklahoma

   Run by

   University of Oklahoma

   See if you can join NCT02241265 on ClinicalTrials.gov